Find your next paid study

Georgiamune IncNCT06028074

~$150 – $4,200

Actual pay is set by the research site.

Phase 1

A Phase 1 Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of PLT012 in Patients With Advanced Solid Tumors

The goal of this clinical trial is to learn about what doses of PLT012 are safe to use in adults with advanced cancers in solid tumors. It will also learn abou…

Advanced Malignant Solid TumorSolid Tumor Cancer

Pilatus Biosciences IncNCT07337525

~$150 – $4,200

Actual pay is set by the research site.

Observational

Clinical Effect of Caffeine Consumption in Patients Taking Oral Terbinafine

The investigators hypothesize that there would be significant changes in blood pressure or heart rate in patients consuming caffeine while taking terbinafine.

Terbinafine Adverse Reaction

Weill Medical College of Cornell UniversityNCT05667246

Actual pay is set by the research site.

Observational

An Experiment Evaluating the Effectiveness of Counter-marketing Food Messages Among Young Adults

The primary objective of this study is to identify the food counter-marketing messages (i.e., messages that describe deceptive marketing tactics used by food c…

Diet QualityYoung Adult HealthCommunication

Stanford UniversityNCT07768462

Actual pay is set by the research site.

A Prospective Registry for Patients at High-Risk for Pancreatic Cancer

This study aims to facilitate discovery and validation of tests for early detection in subjects at high risk for pancreatic ductal adenocarcinoma (PDAC) and to…

Pancreatic CancerPancreatic Ductal AdenocarcinomaPDAC+1 more

Actual pay is set by the research site.

Mayo ClinicNCT06151223

Gastric CancerGastroesophageal Junction CancerBiliary Tract Cancer+1 more

A Phase II, Open-label, Multi-centre Study to Evaluate Safety, Tolerability, Efficacy, PK, and Immunogenicity of AZD0901 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Tumours Expressing Claudin 18.2 (CLARITY-PanTumour01)

The purpose of this study is to assess the safety, tolerability, efficacy, pharmacokinetics (PK), and immunogenicity of AZD0901 as monotherapy and in combinati…

Medullary Thyroid Cancer (MTC)Cultural Adaptation

~$75 – $3,000

Actual pay is set by the research site.

AstraZenecaNCT06219941

Cultural Adaptation of an Educational Tool in Medullary Thyroid Cancer

To find good information about medullary thyroid cancer that is easy to understand and reliable, so researchers aim to design some new educational materials to…

M.D. Anderson Cancer CenterNCT07142005

Actual pay is set by the research site.

Metastatic Pancreatic Ductal AdenocarcinomaPDAC

Phase 2/3 Open Label Randomized Study of Telisotuzumab Adizutecan in Combination With FOLFOX Compared to Standard of Care in Subjects With First-Line Metastatic Pancreatic Ductal Adenocarcinoma - AndroMETa-PDAC-288

Cancer is a condition where cells in a specific part of the body grow and reproduce uncontrollably. The pancreas is a gland behind the stomach that produces a …

Pregnancy ComplicationsMaternal DistressAdverse Birth Outcomes+1 more

~$75 – $3,000

Actual pay is set by the research site.

AbbVieNCT07490301

Observational

Providing an Optimized and emPowered Pregnancy for You (PᵌOPPY) Aim 3: Randomized Controlled Trial

The PᵌOPPY study is designed to support the American Heart Association's mission to improve maternal/infant health outcomes and address inequities in maternal/…

University of Alabama at BirminghamNCT06510075

Actual pay is set by the research site.

Understanding New Cachexia Subtypes Through Observational Epidemiological Research

The UNCOVER study is a longitudinal observational cohort focused on patients at high risk for cancer cachexia. At Kaiser Permanente Northern California, up to …

Advanced Colorectal CarcinomaAdvanced Lung Non-Small Cell CarcinomaAdvanced Pancreatic Adenocarcinoma+5 more

Kaiser PermanenteNCT07776353

~$10 – $1,125

Actual pay is set by the research site.

Glioblastoma MultiformeGlioblastoma Multiforme, AdultSupratentorial Glioblastoma+1 more

Phase II Trial O6-benzylguanine(BG) and Temozolomide(TMZ) Therapy of Glioblastoma Multiforme (GBM) With Infusion of Autologous P140K MGMT+Hematopoietic Progenitors to Protect Hematopoiesis

This phase II trial studies the effect of P140K MGMT hematopoietic stem cells, O6-benzylguanine, temozolomide, and carmustine in treating participants with sup…

Leland MethenyNCT05052957

~$75 – $3,000

Actual pay is set by the research site.

Solid TumorAdvanced CancerMetastatic Cancer+3 more

A Randomized, Multicenter, Open-Label, Phase 2 Study of Givastomig (TJ033721) in Combination With Nivolumab and Chemotherapy Versus Nivolumab and Chemotherapy in Participants With Previously Untreated CLDN18.2 Positive and PD-1L Positive Locally Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Junction Adenocarcinoma

The goal of this clinical trial is to learn if givastomig in combination with standard therapy works to treat adults with cancer in the stomach and/or esophagu…